Skip to main content

Isabella Bank Institute for Entrepreneurship

We are a dedicated institute for student entrepreneurs across campus and beyond. We aim to maximize your success by fostering your entrepreneurial mindset, promote inter-disciplinary collaboration and provide support for the creation and development of your new ventures. Jumpstart your ideas and get involved today!

Tune in for excitement!

Passion. Potential. Pitches. Don't miss any of the 2025 New Venture Challenge excitement.

Tune in Friday, April 11 at 1 p.m. for great ideas and fierce competition. Then, join the judges, mentors, spectators and teams as they see who is going home with thousands of dollars in venture financing. The awards broadcast begins at 6:30 p.m. and one team will walk away as the overall best venture. 

Start your entrepreneurial journey

Central Michigan University’s College of Business Administration is the home of the Isabella Bank Institute for Entrepreneurship and the first Department of Entrepreneurship in the state of Michigan. We are a student-centric hub where experiential, curricular, and external entrepreneurial opportunities intersect.

Our mission is to maximize student success by fostering a campus-wide entrepreneurial mindset that promotes inter-disciplinary collaboration and the creation of new ventures.

We aim to create innovative programming, boost cross-campus and ecosystem collaboration and provide a comprehensive mentoring program.

Our institute provides extracurricular opportunities and is open to all undergraduate and graduate CMU students.

Student opportunities

  • Meet experienced alumni, faculty, entrepreneurs, investors, and other business and political leaders.
  • Learn practical skills, innovative thinking, and connect with mentors and entrepreneurial resources.
  • Attend skill-building workshops and compete in pitch competitions and Hackathons.
  • Take part in special scholarship programs and travel experiences.
  • Pitch your venture at our signature New Venture Challenge event and compete for up to $20,000 in cash awards.

      Find your path

      Are you interested in becoming an entrepreneur?

      Every journey is unique. Explore the opportunities that interest you.

      Learning on medicine’s front lines

      by Sanjna Jassi
      CMU physician and faculty member Dr. Asim Kichloo is a relentless researcher of COVID-19, with numerous published case reports and articles and more in the works.

      When COVID-19 came to Michigan, it met a determined foe from Central Michigan University: Dr. Asim Kichloo.

      mug-kichloo-image0[2]
      Dr. Asim Kichloo

      As a hospital physician, he's one of the first to describe cases of the illness in combination with other conditions such as kidney disease, Epstein-Barr virus, lupus pneumonitis, heart arrhythmia, hypercoagulability (abnormal blood clotting) and an inflammatory syndrome known as HLH.

      As a relentless researcher, he's the lead author on nine published case reports and articles on COVID-19 so far, with more in the works.

      "My main attention is on understanding this disease more," he said. "Research is my passion."

      That research includes:

      • COVID-19 case reports that address correlation with other disease processes.
      • A proposed book chapter on therapeutic drug management of COVID-19.
      • A study on protocols for handling the bodies of COVID-19 victims.
      • An exploration of COVID-19 and telemedicine.
      • A study of similarities between lung damage from COVID-19 and from vaping.
      • A study of how the disease affects patients' psyches.

      All told, he expects to complete 15 COVID-related projects by year's end, a number he says is on the higher end of the spectrum for academic publishing.

      “It is always a team effort. It is never just me. And the team is CMU.” — Dr. Asim Kichloo, COVID-19 researcher

      Kichloo said with a new disease, practically everything is in an experimental stage.

      For example, steroids were not a standard treatment for COVID patients back in April, but Kichloo and his colleagues found them effective for treating a COVID patient who also had lupus. In this situation and others, they wrote up case reports to share their findings with the medical community.

      "We were the first ones to diagnose these and connect the dots," he said. "All these basic questions that were not answered or even raised, we raised them."

      Taking the lead

      Kichloo, who joined CMU four years ago, is a doctor of internal medicine at Ascension St. Mary's Hospital in Saginaw, Michigan. He's an associate professor and the clerkship director for CMU's College of Medicine. He also was on the front lines when COVID-19 cases began to surge in mid-Michigan nursing homes in March.

      "I saw only COVID patients every day and every weekend," he said.

      He and his lab team began to study how the illness affected patients with other conditions, knowing that what they learned could point the way to more effective treatments.

      "We are doing all we can to understand and treat it based on the best possible limited evidence. Somebody has to take the lead, and if it is me, it is me."

      'The team is CMU'

      Kichloo is quick to add it is not him alone.

      "It is always a team effort. It is never just me," he said. "And the team is CMU."

      Kichloo said the CMU medical students and residents he leads in the lab tirelessly push the boundaries of knowledge about the disease.

      "They want to do something to engage, to work for the betterment of patients," he said. "They find the time beyond their rotations, beyond their examinations, beyond their classes.

      "I am the lab team lead, but I am nothing without my team."

      Saginaw native and fourth-year CMU medical student Michael Albosta is a member of that team who co-authored several of Kichloo's publications. He began researching with Kichloo a year ago, pre-pandemic, though he said it's not officially part of his coursework.

      "Dr. Kichloo has been a huge proponent of students getting involved in research," he said. "It's not required, but it's absolutely beneficial."

      Fighting against COVID-19

      Here are a few examples of CMU faculty addressing COVID-19 in their work and research:

      Expert sources for media

      Questions?